select a format

Single User License
USD 250 INR 16040
Site License
USD 500 INR 32080
Corporate User License
USD 750 INR 48120

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Genomic Health Inc (GHDX)-Medical Equipment-Deals and Alliances Profile

Genomic Health Inc (GHDX)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME16224D
  • |
  • Pages: 40
  • |
  • April 2017
  • |
  • |
  Request for Sample Report

Executive Summary

Genomic Health Inc (Genomic Health) is a provider of genomic-based clinical laboratory services for the treatment of cancer. The company's commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, and Onco type DX prostate cancer test. It perform extensive research and development activities to optimize the treatment of urologic cancers including prostate, bladder, and kidney cancers, and additional treatment decisions in breast and colon cancers. Genomic Health develops these products using its Onco type DX platform, a technology which uses RT-PCR approach to improve cancer treatment decisions. The company has operations in the US, Europe, and Asia through its subsidiaries and offices. Genomic Health is headquartered in Redwood City, California, the US.

Genomic Health Inc (GHDX)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Genomic Health Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Genomic Health Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Genomic Health Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Genomic Health Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9

Genomic Health Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Genomic Health Inc, Medical Equipment, Deal Details 12

Venture Financing 12

InVitae Raises USD120 Million in Series F Venture Financing 12

Invitae Raises US$40 Million In Series E Financing 13

Partnerships 15

New England Biolabs Enters into Licensing Agreement with Genomic Health for Ribosomal RNA Depletion Technology 15

Genomic Health Enters Into In-Licensing Agreement With Almac To Develop And Commercialize Anthracycline Chemotherapy Benefit Test 15

NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For Oncotype DX Tests 17

Genomic Health and Epic Sciences Enter into Distribution Agreement 18

Philips Electronics Enters into Agreement with Genomic Health 19

Specialised Therapeutics Enters Into Distribution Agreement With Genomic Health For Oncotype DX Test 19

Genomic Health Enters Into Co-Development Agreement With OncoMed Pharma 20

Equity Offering 21

Genomic Health Files Registration Statement For Public Offering Of Shares To Raise Up To US$334 Million 21

Genomic Health Inc-Key Competitors 23

Key Employees 24

Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Recent Developments 26

Financial Announcements 26

Feb 14, 2017: Genomic Health Announces 2016 Fourth Quarter and Year-End Financial Results, Provides 2017 Financial Outlook 26

Nov 01, 2016: Genomic Health Reports Third Consecutive Quarter of Double-Digit Revenue Growth in Announcement of Third Quarter 2016 Financial Results 28

Aug 02, 2016: Genomic Health Reports Continued Double-Digit Growth in Announcement of Second Quarter 2016 Financial Results, Raises Low End of Full-Year Test and Revenue Guidance 30

May 04, 2016: Genomic Health Reports Double-Digit Revenue and Test Growth in Announcement of First Quarter 2016 Financial Results 32

Feb 10, 2016: Genomic Health Announces 2016 Financial Outlook and Provides 2015 Fourth Quarter and Year-End Financial Results 33

Product News 35

03/11/2016: Genomic Health Announces Five-year Outcomes from International 'PlanB' Study Demonstrating the Clinical Utility of Oncotype DX in Node-positive and High-risk Node-negative Breast Cancer 35

03/09/2016: German National Cancer Guidelines Distinguish Oncotype DX as First and Only Multi-gene Breast Cancer Test with 1A Level of Evidence 36

03/01/2016: Journal of Clinical Oncology Publishes Prospective Outcomes Results from Large International Trial Using Oncotype DX 37

01/11/2016: Genomic Health Announces Plans to Launch Liquid Biopsy Mutation Panel in 2016 38

Other Significant Developments 39

Jan 08, 2016: Genomic Health Announces Preliminary 2015 Revenue and Confirms 2016 Growth Expectations 39

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40

List of Figures

Genomic Health Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Genomic Health Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Genomic Health Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Genomic Health Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Genomic Health Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Genomic Health Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7

Genomic Health Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Genomic Health Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9

List of Tables

Genomic Health Inc, Medical Equipment, Key Facts, 2015 1

Genomic Health Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Genomic Health Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Genomic Health Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Genomic Health Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Genomic Health Inc, Deals By Market, 2011 to YTD 2017 9

Genomic Health Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

InVitae Raises USD120 Million in Series F Venture Financing 12

Invitae Raises US$40 Million In Series E Financing 13

New England Biolabs Enters into Licensing Agreement with Genomic Health for Ribosomal RNA Depletion Technology 15

Genomic Health Enters Into In-Licensing Agreement With Almac To Develop And Commercialize Anthracycline Chemotherapy Benefit Test 15

NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For Oncotype DX Tests 17

Genomic Health and Epic Sciences Enter into Distribution Agreement 18

Philips Electronics Enters into Agreement with Genomic Health 19

Specialised Therapeutics Enters Into Distribution Agreement With Genomic Health For Oncotype DX Test 19

Genomic Health Enters Into Co-Development Agreement With OncoMed Pharma 20

Genomic Health Files Registration Statement For Public Offering Of Shares To Raise Up To US$334 Million 21

Genomic Health Inc, Key Competitors 23

Genomic Health Inc, Key Employees 24

Genomic Health Inc, Other Locations 25

Genomic Health Inc, Subsidiaries 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com